Log in to save to my catalogue

BMJ-British Medical Journal; Diabetes drug linked to increased risk of heart failure

BMJ-British Medical Journal; Diabetes drug linked to increased risk of heart failure

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205559686

BMJ-British Medical Journal; Diabetes drug linked to increased risk of heart failure

About this item

Full title

BMJ-British Medical Journal; Diabetes drug linked to increased risk of heart failure

Publisher

Atlanta: NewsRx

Journal title

Diabetes Week, 2009, p.154

Language

English

Publication information

Publisher

Atlanta: NewsRx

More information

Scope and Contents

Contents

2009 AUG 31 - ( NewsRx.com) -- Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today (see also

Alternative Titles

Full title

BMJ-British Medical Journal; Diabetes drug linked to increased risk of heart failure

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_205559686

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205559686

Other Identifiers

ISSN

1537-1425

E-ISSN

1537-1433

How to access this item